Epigenomics AG

Industry:	Medical Testing & Clinical Laboratories
Revenues:	$12.1 Million
Employees:	142

Description

Epigenomics AG is a Germany-based company engaged in the molecular diagnostics sector. It divides its products into two areas: solutions for early diagnosis of cancer and products for special diagnosis of cancer. Epigenomics AG produces and develops tests that help in the diagnosis of the colorectal, prostate and lung cancer. The Company also offers services in the field of identification and development of methylated deoxyribonucleic acid (DNA) biomarkers. Industry partners and the medical and life science communities can access the Company’s portfolio of approximately 150 filed patent families covering DNA methylation technologies and biomarkers, as well as its DNA methylation expertise through research products, biomarker services, in vitro diagnostics (IVD) development collaborations and licensing. It develops its solutions together with its commercial partners, Abbott Molecular Inc and Quest Diagnostics Inc. The Company has a subsidiary in the United States, Epigenomics, Inc.

View More Statistics

Site Statistics

Monthly Unique Visitors:	321
Site Rank:	2,873,636
Trust Rating:	Neutral
Stats by

News Archive

Research and Markets: Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015. Business Wire; 6/17/2009 ...Clinical Diagnostics Inc. * Ventana Medical Systems, Inc. * Digene Corporation * BRAHMS Aktiengesellschaft * Epigenomics AG * Epigenomics AG Pipeline Products * Hain Lifescience GmbH * Invitek Biotechnolgy & Biodesign Ltd. * Mindray Medical... ...more

Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015. M2 Presswire; 6/17/2009 ...Clinical Diagnostics Inc. - Ventana Medical Systems, Inc. - Digene Corporation - BRAHMS Aktiengesellschaft - Epigenomics AG - Epigenomics AG Pipeline Products - Hain Lifescience GmbH - Invitek Biotechnolgy & Biodesign Ltd. - Mindray Medical... ...more

A Comprehensive Report on Germany's In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015. M2 Presswire; 6/2/2009 ...biognostic GmbH - AdnaGen AG - AESKU.DIAGNOSTICS - BRAHMS Aktiengesellschaft - BioRepair GmbH - Centronic GmbH - Epigenomics AG - Epigenomics AG Pipeline Products - Hain Lifescience GmbH - Invitek Biotechnolgy & Biodesign Ltd. - Serion Immundiagnostica... ...more